Pankaj Bhargava

6.2k citations
125 papers · 4.3k · 1 hit paper · h-index 33

Impact in

  • Hepatology top 1%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Oncology top 1%
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies

Papers in

    • Renal cell carcinoma treatment 16
    • Gastric Cancer Management and Outcomes 13
    • Lung Cancer Treatments and Mutations 12
    • Colorectal Cancer Treatments and Studies 24
    • Cancer Treatment and Pharmacology 13

Pankaj Bhargava

120 papers receiving 4.2k citations

Pankaj Bhargava's Hit Papers

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303) 2010 · 679 citations
6790+5+10Years since publication200400600

Peers

Pankaj Bhargava
Comparison fields: 5 of 132
  • Hepatology 568
  • Oncology 1.9k
  • Cancer Research 862
  • Pulmonary and Respiratory Medicine 1.1k
  • Pathology and Forensic Medicine 533
Replace Hong Bu with:
Hong Bu China
Hai T. Tran United States
Kenichi Kohashi Japan
Yoshiyuki Nakajima Japan
Song Cheol Kim South Korea
Hideki Fujii Japan
Ronald A. Ignotz United States
Gening Jiang China
Bing Liu China
Chul Woo Kim South Korea
Pankaj Bhargava relative to Hong Bu China Hong Bu's profile →
Citations per field
00.5×1.5×1.9×
Hong Bu · 1×
Citations per year

Countries citing papers authored by Pankaj Bhargava

Since Specialization
Citations

This map shows the geographic impact of Pankaj Bhargava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pankaj Bhargava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pankaj Bhargava more than expected).

Fields of papers citing papers by Pankaj Bhargava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pankaj Bhargava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pankaj Bhargava. The network helps show where Pankaj Bhargava may publish in the future.

Co-authors

The 25 scholars most cited alongside Pankaj Bhargava, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pankaj Bhargava Line = papers co-authored together Pankaj Bhargava links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
Hit paper breakdown →
2010679
2 2006302
3 2009229
4 2006217
5 2012207
6 2007190
7
A Phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer.
1999120
8 2011105
9 201596
10 201189
11 201286
12 201183
13 200480
14 200170
15 200668
16 200867
17 200763
18
A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers.
200163
19 200059
20 201355

About Pankaj Bhargava

Pankaj Bhargava is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Mechanical Engineering, having authored 125 papers that have together received 4.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (24 papers), Renal cell carcinoma treatment (16 papers), Cancer Treatment and Pharmacology (13 papers), Gastric Cancer Management and Outcomes (13 papers), Lung Cancer Treatments and Mutations (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cancer Genomics and Diagnostics (11 papers) and Additive Manufacturing Materials and Processes (10 papers). The work is most often cited by research in Hepatology (568 citations), Oncology (1.9k citations), Cancer Research (862 citations), Pulmonary and Respiratory Medicine (1.1k citations) and Pathology and Forensic Medicine (533 citations). Pankaj Bhargava has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Lawrence S. Blaszkowsky, Peter C. Enzinger, Keith Stuart, Jeffrey W. Clark, Andrew X. Zhu, David P. Ryan, C. P. Paul, Charles S. Fuchs, Alona Muzikansky and Kerry Horgan. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Optics & Laser Technology, Clinical Cancer Research and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact